1-4 of 4
Naoki Harada
Close
Sort by
Journal Articles

Obinutuzumab-Retreatment in Combination with Bendamustine Is Effective for Obinutuzumab Resistant Models in Vitro and In Vivo

Yoriko Yamashita-Kashima, PhD, Natsumi Kawasaki, PhD, Keigo Yorozu, DVM, PhD, Shigeki Yoshiura, PhD, Takaaki Fujimura, MS, Mitsue Kurasawa, MS, Naoki Harada, PhD, Yasushi Yoshimura, MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-136877
Published: 2020
Journal Articles

Once-Weekly Subcutaneous Bortezomib Plus Oral Cyclophosphamide and Dexamethasone Therapy For Relapsed Or Refractory Multiple Myeloma

Yasushi Takamatsu, MD, PhD, Yutaka Imamura, MD, Tomonori Nakazato, MD, Naokuni Uike, MD, PhD, Kaname Miyashita, MD, Yoshio Saburi, MD, PhD, Naoki Harada, MD, Shuichi Ota, MD, PhD, Rie Imamura, MD, Toshihiro Miyamoto, MD
Journal: Blood
Blood (2013) 122 (21): 5382.
https://doi.org/10.1182/blood.V122.21.5382.5382
Published: 2013
Journal Articles

Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis

Takuro Kuriyama, Katsuto Takenaka, Kentaro Kohno, Takuji Yamauchi, Shinya Daitoku, Goichi Yoshimoto, Yoshikane Kikushige, Junji Kishimoto, Yasunobu Abe, Naoki Harada, Toshihiro Miyamoto, Hiromi Iwasaki, Takanori Teshima, Koichi Akashi
Journal: Blood
Blood (2012) 120 (19): 4058–4067.
https://doi.org/10.1182/blood-2012-02-408864
Published: 2012
Includes: Supplemental data
Journal Articles

Myocardial ischemia following allogeneic bone marrow transplantation: possible implication of tacrolimus overdose

Naoyuki Uchida, Shuichi Taniguchi, Naoki Harada, Tsunefumi Shibuya
Journal: Blood
Blood (2000) 96 (1): 371–372.
https://doi.org/10.1182/blood.V96.1.371
Published: 2000